Publications by authors named "Esi Domi"

Activity of central amygdala (CeA) PKCδ expressing neurons has been linked to appetite regulation, anxiety-like behaviors, pain sensitivity, and addiction-related behaviors. Studies of the role that CeA PKCδ+ neurons play in these behaviors have largely been carried out in mice, and genetic tools that would allow selective manipulation of PKCδ+ cells in rats have been lacking. Here, we used a CRISPR/Cas9 strategy to generate a transgenic -cre knock-in rat and characterized this model using anatomical, electrophysiological, and behavioral approaches in both sexes.

View Article and Find Full Text PDF

Background: Sex is an important factor in the progression and treatment of alcohol addiction, and therapeutic approaches may have to be tailored to potential sex differences. This highlights the importance of understanding sex differences in behaviors that reflect key elements of clinical alcohol addiction, such as continued use despite negative consequences ("compulsive use"). Studies in experimental animals can help provide an understanding of the role sex plays to influence these behaviors.

View Article and Find Full Text PDF

The Nociceptin/Orphanin FQ (N/OFQ) peptide and its receptor NOP are highly expressed within several regions of the mesolimbic system, including the ventral tegmental area (VTA). Evidence indicates that the N/OFQ-NOP receptor system is involved in reward processing and historically it has been proposed that activation of NOP receptors attenuates the motivation for substances of abuse. However, recent findings demonstrated that drug self-administration and relapse to drug-seeking are also attenuated after administration of NOP receptor antagonists.

View Article and Find Full Text PDF

Nicotine robustly sustains smoking behavior by acting as a primary reinforcer and by enhancing the incentive salience of the nicotine-associated stimuli. The motivational effects produced by environmental cues associated with nicotine delivery can progressively manifest during abstinence resulting in reinstatement of nicotine seeking. However, how the activity in reward neuronal circuits is transformed during abstinence-induced nicotine seeking is not yet fully understood.

View Article and Find Full Text PDF

Alcohol use despite negative consequences is a core phenomenon of alcohol addiction. We recently used alcohol self-administration that is resistant to footshock punishment as a model of this behavior, and found that activity of PKCδ + GABAergic neurons in the central amygdala (CeA) is a determinant of individual susceptibility for punishment resistance. In the present study, we examined whether activation of GABA receptors in CeA can attenuate the activity of PKCδ + neurons in this region, and whether this will result in suppression of punishment- resistant alcohol self-administration in the minority of rats that show this behavior.

View Article and Find Full Text PDF
Article Synopsis
  • Alcohol use disorder (AUD) involves a loss of control over drinking despite negative consequences and is linked to significant changes in brain areas responsible for reward and decision-making.
  • Epigenetic mechanisms, particularly DNA methylation, histone modification, and non-coding RNAs, play a crucial role in how alcohol affects gene expression long-term.
  • While there is promise for treatments targeting epigenetic changes, more research is needed to explore their influence on brain circuits and behaviors related to AUD.
View Article and Find Full Text PDF

Excessive fear is a hallmark of anxiety disorders, a major cause of disease burden worldwide. Substantial evidence supports a role of prefrontal cortex-amygdala circuits in the regulation of fear and anxiety, but the molecular mechanisms that regulate their activity remain poorly understood. Here, we show that downregulation of the histone methyltransferase PRDM2 in the dorsomedial prefrontal cortex enhances fear expression by modulating fear memory consolidation.

View Article and Find Full Text PDF

The neuropeptide S (NPS) is the endogenous ligand of the NPS receptor (NPSR). The NPSR is widely expressed in brain regions that process emotional and affective behavior. NPS possesses a unique physio-pharmacological profile, being anxiolytic and promoting arousal at the same time.

View Article and Find Full Text PDF
Article Synopsis
  • The nociceptin/orphanin FQ (N/OFQ)-NOP receptor system shows promise for treating substance use disorders, particularly in blocking alcohol abuse, and this study investigates its potential for smoking cessation.
  • Researchers used NOP receptor knockout rats and a specific antagonist, LY2817412, to assess nicotine motivation and self-administration behaviors.
  • Results indicated that blocking NOP receptors decreased nicotine intake and motivation, with effects primarily observed when the antagonist was injected into the ventral tegmental area, suggesting that NOP antagonism could be a viable treatment for quitting smoking.
View Article and Find Full Text PDF

Alcohol intake remains controlled in a majority of users but becomes "compulsive," i.e., continues despite adverse consequences, in a minority who develop alcohol addiction.

View Article and Find Full Text PDF

Alcohol addiction is a chronic relapsing brain disease characterized by an impaired ability to stop or control alcohol use despite adverse consequences. A main challenge of addiction treatment is to prevent relapse, which occurs in more than >50% of newly abstinent patients with alcohol disorder within 3 months. In people suffering from alcohol addiction, stressful events, drug-associated cues and contexts, or re-exposure to a small amount of alcohol trigger a chain of behaviors that frequently culminates in relapse.

View Article and Find Full Text PDF

Comorbidity between alcohol use and anxiety disorders is associated with more severe symptoms and poorer treatment outcomes than either of the conditions alone. There is a well-known link between stress and the development of these disorders, with post-traumatic stress disorder as a prototypic example. Post-traumatic stress disorder can arise as a consequence of experiencing traumatic events firsthand and also after witnessing them.

View Article and Find Full Text PDF

Aims: Despite a general decline in tobacco use in the last decades, the prevalence of tobacco smoking in individuals with alcohol use disorder (AUD) remains substantial (45-50%). Importantly, the co-use of both substances potentiates the adverse effects, making it a significant public health problem. Substantial evidence suggests that AUD and Tobacco use disorder (TUD) may share common mechanisms.

View Article and Find Full Text PDF

Background: Alcohol addiction is characterized by persistent neuroadaptations in brain structures involved in motivation, emotion, and decision making, including the medial prefrontal cortex, the nucleus accumbens, and the amygdala. We previously reported that induction of alcohol dependence was associated with long-term changes in the expression of genes involved in neurotransmitter release. Specifically, Syt1, which plays a key role in neurotransmitter release and neuronal functions, was downregulated.

View Article and Find Full Text PDF

Background And Purpose: Alcohol and nicotine use disorders are commonly comorbid. Both alcohol and nicotine can activate opioid systems in reward-related brain regions, leading to adaptive changes in opioid signalling upon chronic exposure. The potential role of these adaptations for comorbidity is presently unknown.

View Article and Find Full Text PDF

Rationale: Peroxisome Proliferator Activator receptors (PPARs) are intracellular receptors that function as transcription factors, which regulate specific metabolic and inflammatory processes. PPARs are broadly distributed in the body and are also expressed in the central nervous system, especially in areas involved in addiction-related behavioral responses. Recent studies support a role of PPARs in alcoholism and pioglitazone: a PPARγ agonist used for treatment of type 2 diabetes showed efficacy in reducing alcohol drinking, stress-induced relapse, and alcohol withdrawal syndrome in rats.

View Article and Find Full Text PDF

An isoform of peroxisome proliferator-activated receptors (PPARs), PPARγ, is the receptor for the thiazolidinedione class of anti-diabetic medications including pioglitazone. Neuroanatomical data indicate PPARγ localization in brain areas involved in drug addiction. Preclinical and clinical data have shown that pioglitazone reduces alcohol and opioid self-administration, relapse to drug seeking, and plays a role in emotional responses.

View Article and Find Full Text PDF
Article Synopsis
  • Epigenetic enzymes are crucial for long-term gene expression changes and might play a role in substance abuse, particularly alcohol addiction, although research in this area is limited.
  • A study identified 11 epigenetic enzymes that are significantly altered in brain regions of alcohol-dependent rats compared to controls, with a focus on KDM6B, which shows specific dysregulation in areas linked to addiction.
  • The study found that increased KDM6B in alcohol-dependent rats correlates with reduced trimethylation at histone H3K27 and affects the IL-6 signaling pathway, highlighting a new signaling pathway related to inflammation and alcohol addiction development.
View Article and Find Full Text PDF

Recent animal models of alcohol use disorder (AUD) are centered in capturing individual vulnerability differences in disease progression. Here, we used genetically selected Marchigian Sardinian alcohol-preferring (msP) and Wistars rats to apply a multidimensional model of AUD adapted from a previously described DSM-IV/DSM-5 multisymptomatic cocaine addiction model. As proof of concept, we hypothesized that msP rats, genetically selected for excessive drinking, would be more prone to develop dependence-like behavior compared to Wistars.

View Article and Find Full Text PDF

Alcohol addiction leads to increased choice of alcohol over healthy rewards. We established an exclusive choice procedure in which ~15% of outbred rats chose alcohol over a high-value reward. These animals displayed addiction-like traits, including high motivation to obtain alcohol and pursuit of this drug despite adverse consequences.

View Article and Find Full Text PDF

Approved pharmacological treatments for alcohol use disorder are limited in their effectiveness, and new drugs that can easily be translated into the clinic are warranted. One of those candidates is oxytocin because of its interaction with several alcohol-induced effects. Alcohol-dependent rats as well as post-mortem brains of human alcoholics and controls were analyzed for the expression of the oxytocin system by qRT-PCR, in situ hybridization, receptor autoradiography ([I]OVTA binding), and immunohistochemistry.

View Article and Find Full Text PDF

Binge alcohol drinking has emerged as a typical phenomenon in young people. This pattern of drinking, repeatedly leading to extremely high blood and brain alcohol levels and intoxication is associated with severe risks of neurodegeneration and cognitive damage. Mechanisms involved in excitotoxicity and neuroinflammation are pivotal elements in alcohol-induced neurotoxicity.

View Article and Find Full Text PDF
Article Synopsis
  • PPARγ, a receptor involved in insulin resistance treatment, is mostly found in brain regions that handle motivation and emotion, impacting anxiety and stress responses in mice.
  • Activating PPARγ with pioglitazone doesn't change baseline anxiety but protects against stress-induced anxiety; however, mice lacking PPARγ in their neurons show increased anxiety and stress sensitivity.
  • The study highlights that neuronal PPARγ is crucial for managing stress responses, especially in the amygdala, where its activation can reduce anxiety during stressful situations.
View Article and Find Full Text PDF